SABBY MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$241,000
-81.7%
70,431
-84.0%
0.03%
-82.3%
Q2 2021$1,320,000
-22.9%
441,473
-16.7%
0.19%
-44.1%
Q1 2021$1,712,000
+5606.7%
530,000
+2255.6%
0.33%
+16550.0%
Q2 2016$30,000
-88.2%
22,500
-25.0%
0.00%
-80.0%
Q3 2015$254,000
+247.9%
30,000
+451.7%
0.01%
+233.3%
Q3 2014$73,000
-92.5%
5,438
-92.2%
0.00%
-95.2%
Q4 2013$967,000
+104.0%
70,000
+139.8%
0.06%
+93.8%
Q2 2013$474,00029,1880.03%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders